Eyelid margin biofilm

"Eyelid margin debris/biofilm" is not a molecular target such as a receptor, enzyme, transporter, or protein. Instead, it refers to the **accumulation of bacterial biofilms and associated debris** along the edge of the eyelids. This material is primarily composed of bacteria (notably *Staphylococcus* species), their extracellular matrix (biofilm), desquamated epithelial cells, keratinized material, and other organic matter. The presence and persistence of this **biofilm on the lid margin** play a central role in chronic ocular surface diseases such as blepharitis and meibomian gland dysfunction by blocking glandular outflow and promoting inflammation[3][4][5]. Removal strategies are mechanical (e.g., BlephEx device microblepharoexfoliation), enzymatic (okra-based ZEST procedure), thermal/mechanical expression (Lipiflow/TearCare systems), or involve daily hygiene routines with specialized cleansers[1][2]. These interventions aim to reduce microbial load and restore normal function but do not target a single molecular entity. Because "Eyelid margin debris/biofilm removal" describes a **procedure/therapeutic approach rather than an individual molecule/receptor**, it is not considered a canonical therapeutic target. The entry should be flagged as incorrect for structured drug-target databases that require specific molecular targets. --- **Key points supporting 'is_incorrect':** > "Biofilm busting 101... Methods to remove ocular biofilms vary in mechanism but attempt to improve the ocular surface..." [1] > "Mechanical debridement/scaling... removes keratin from meibomian gland orifices..." [2] > "Biofilm is more than just crusting on lids... It is nearly invisible layer that covers entire lid margin." [3]

Other names

Eyelid margin debrisLid margin biofilmOcular surface biofilmLid debris

Mechanical removal of biofilm and debris from the eyelid margin using devices or sponges soaked in cleansing solutions[1][2][3] Enzymatic degradation of biofilms with specific gels or solutions[1]